Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
Recruiting
This phase I trial identifies the best dose and clinical benefit of giving pemigatinib following standard induction chemotherapy in patients with newly diagnosed acute myeloid leukemia. Pemigatinib selectively inhibits FGFR (fibroblast growth factor receptor) activity, a receptor that may contribute to the growth of leukemia cells. The genetic changes responsible for activating the growth of leukemia cells can be unique to each patient and can change during the course of the disease. Chemotherap... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/05/2024
Locations: OHSU Knight Cancer Institute, Portland, Oregon +1 locations
Conditions: Acute Myeloid Leukemia
Innovative Multimodal and Attention Training to Improve Emotion Communication in Veterans With TBI and PTSD
Recruiting
Poor emotion recognition has been associated with poor quality of interpersonal relationships, loss of employment, behavioral problems, reduced social reintegration, social isolation and even suicide. Deficits in emotion recognition are common in traumatic brain injury (TBI) and in post-traumatic stress disorder (PTSD) but these deficits have not been well studied in Veterans with both mild TBI (mTBI) and PTSD. Currently there are no interventions for emotion recognition in Veterans with mTBI an... Read More
Gender:
ALL
Ages:
Between 25 years and 50 years
Trial Updated:
12/05/2024
Locations: North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida
Conditions: Brain Injury, Post Traumatic Stress Disorder
Topical Treatment for TMJ Arthralgia
Recruiting
The goal of this clinical trial is to evaluate the efficacy of topical 2.5% hydrocortisone in TMJ arthralgia. The main questions it aims to answer are: * How does pain reduction compare? * How does improvement in jaw function limitation compare? * How do side effects compare? Participants will * On day 1 be examined and report their pain level and jaw function limitation * On days 1-21, apply their cream four times a day * On day 21, report their pain level, jaw function limitation, compliance... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/05/2024
Locations: Arthur A. Dugoni School of Dentistry, University of the Pacific, San Francisco, California
Conditions: TMJ Pain
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
Recruiting
The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D\&E) in the clinic setting.
Gender:
FEMALE
Ages:
Between 18 years and 55 years
Trial Updated:
12/05/2024
Locations: Comprehensive Women's Health Center, Denver, Colorado
Conditions: Hemorrhage
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Recruiting
The primary objective of the present pilot, sequential, multiple-assignment randomized trial (Pilot SMART) is to determine feasibility and acceptability of delivering (from the perspective of the treatment/intervention staff) and receiving (from the perspective of the patient) an adaptive intervention for reducing rates of opioid misuse and preventing development of opioid use disorder in individuals hospitalized for traumatic injury. A complimentary secondary objective is to ensure the feasibil... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
12/05/2024
Locations: UW Health, Madison, Wisconsin +1 locations
Conditions: Opioid Misuse, Trauma Injury
Interprofessional Pharmacogenomics (IPGx) Registry and Repository
Recruiting
This program collects genetic and health information to help doctors choose the right medications for patients.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/05/2024
Locations: Texas A&M Family Care, Bryan, Texas
Conditions: Diabetes, Cholesterol, Cancer, Blood Pressure Disorders, Heart Disease, Respiratory Ilness, COPD, Adverse Drug Reaction (ADR), Poly Pharmacy
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
Recruiting
Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/05/2024
Locations: UCLA Medical Centre, Los Angeles, California +12 locations
Conditions: Cardiac Transplant Disorder
Post-Market Study to Assess iTind Safety in Comparison to UroLift
Recruiting
The study objective is to evaluate the safety of the iTind device comparied to UroLift.
Gender:
MALE
Ages:
50 years and above
Trial Updated:
12/05/2024
Locations: Arizona Urology Specialists, Tucson, Arizona +17 locations
Conditions: Benign Prostatic Hyperplasia (BPH)
Neuromodulation and Fatigue
Recruiting
In this project, we aim to determine any potential effects of a weak electrical current applied to the neck or thoracic area on functional capacity and muscle activation. Healthy individuals will participate in one familiarization followed by three experimental sessions. Fatigability and motor function will be assessed in each test session.
Gender:
ALL
Ages:
Between 18 years and 50 years
Trial Updated:
12/05/2024
Locations: University of Oklahoma, Norman, Oklahoma
Conditions: Healthy Aging, Fatigue
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
Recruiting
To learn if adding a healthy person's natural killer (NK) cells to the combination of Azacitidine and Venetoclax can help to control AML. NK cells are cancer- and infection-fighting immune cells.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/05/2024
Locations: M.D. Anderson Cancer Center, Houston, Texas
Conditions: Acute Myeloid Leukemia
Virtual Reality Devices As an Adjunct to Usual Care for Patients with Sickle Cell Disease Experiencing Vaso-Occlusive Crises
Recruiting
This study aims to evaluate the use of virtual reality as an adjunct to standard care for patients with sickle cell disease experiencing vaso-occlusive crises.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/05/2024
Locations: University of Maryland Medical Systems, Baltimore, Maryland
Conditions: Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease, Acute Pain
Cognitive Rehabilitation Following Breast Cancer Treatment
Recruiting
The goal of this proposed project is to evaluate the feasibility and preliminary effect of metacognitive strategy training to improve activity performance, cognition, and quality of life in breast cancer survivors with cancer-related cognitive impairment (CRCI). The other goal of this proposed project is to examine the effects of CO-OP on resting (rsFC)- and task-state functional connectivity as compared to an inactive control group.
Gender:
FEMALE
Ages:
Between 20 years and 75 years
Trial Updated:
12/05/2024
Locations: University of Missouri, Columbia, Missouri
Conditions: Breast Cancer Female